KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Net Income (2016 - 2025)

Charles River Laboratories International (CRL) has 16 years of Net Income data on record, last reported at -$276.3 million in Q4 2025.

  • For Q4 2025, Net Income fell 29.26% year-over-year to -$276.3 million; the TTM value through Dec 2025 reached -$142.2 million, down 662.11%, while the annual FY2025 figure was -$142.2 million, 662.11% down from the prior year.
  • Net Income reached -$276.3 million in Q4 2025 per CRL's latest filing, down from $55.6 million in the prior quarter.
  • Across five years, Net Income topped out at $189.1 million in Q4 2022 and bottomed at -$276.3 million in Q4 2025.
  • Average Net Income over 5 years is $62.7 million, with a median of $92.1 million recorded in 2021.
  • Peak YoY movement for Net Income: surged 48.94% in 2022, then plummeted 213.12% in 2024.
  • A 5-year view of Net Income shows it stood at $139.8 million in 2021, then surged by 35.24% to $189.1 million in 2022, then decreased by 0.08% to $189.0 million in 2023, then tumbled by 213.12% to -$213.7 million in 2024, then decreased by 29.26% to -$276.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Net Income were -$276.3 million in Q4 2025, $55.6 million in Q3 2025, and $52.7 million in Q2 2025.